Safety assessments
ADVERSE EVENTS, ADVERSE EVENT
All adverse events were graded according to Common Terminology Criteria for Adverse Events version 5.0. Pharmacovigilance was performed according to the ICH-GCP E6 (R2) guidelines. An independent data-monitoring committee regularly assessed outcomes and serious adverse events.